Pure Autonomic Failure
Showing 1 - 25 of >10,000
Biomarkers of Risk of Parkinson Disease
Active, not recruiting
- Parkinson Disease
- +2 more
- 6-[18F]Fluorodopamine
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 13, 2023
Supine Hypertension, Autonomic Failure Trial in Nashville (continuous positive airway pressure (CPAP), Placebo)
Recruiting
- Supine Hypertension
- Autonomic Failure
- continuous positive airway pressure (CPAP)
- Placebo
-
Nashville, TennesseeAutonomic Dysfunction Center/ Vanderbilt University Medical Cent
Oct 24, 2022
Clinical Laboratory Evaluation of Chronic Autonomic Failure
Recruiting
- Parkinson's Disease
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Oct 19, 2022
Autonomic Failure, Pure Autonomic Failure, Parkinson Disease Trial in Nashville ([18F]FDOPA, Carbidopa 200mg oral dose,
Recruiting
- Autonomic Failure
- +4 more
- [18F]FDOPA
- +2 more
-
Nashville, TennesseeVanderbilt University Medical Center
Apr 14, 2022
Neurogenic Orthostatic Hypotension, Autonomic Failure Trial in Calgary (CO2 ReHaler)
Not yet recruiting
- Neurogenic Orthostatic Hypotension
- Autonomic Failure
- CO2 ReHaler
-
Calgary, Alberta, CanadaUniversity of Calgary
Jun 16, 2023
Neurogenic Orthostatic Hypotension, Autonomic Failure, Pure Autonomic Failure Trial in Nashville (Midodrine, Placebo pill,
Recruiting
- Neurogenic Orthostatic Hypotension
- +4 more
- Midodrine
- +3 more
-
Nashville, TennesseeVanderbilt University Medical Center
May 31, 2022
Hypertension, Pure Autonomic Failure, Multiple System Atrophy Trial in Nashville (Passive heat stress, Control (non-heating))
Completed
- Hypertension
- +3 more
- Passive heat stress
- Control (non-heating)
-
Nashville, TennesseeVanderbilt University
Dec 25, 2021
Neurogenic Orthostatic Hypotension Trial in New York, Nashville (Atomoxetine, Placebo)
Active, not recruiting
- Neurogenic Orthostatic Hypotension
- Atomoxetine
- Placebo
-
New York, New York
- +1 more
Aug 22, 2022
Autonomic Failure, Pure Autonomic Failure, Multiple System Atrophy Trial in Nashville (Active CPAP, Sham CPAP, Sleeping in a
Recruiting
- Autonomic Failure
- +5 more
- Active CPAP
- +2 more
-
Nashville, TennesseeAutonomic Dysfunction Center/ Vanderbilt University Medical Cent
Aug 3, 2022
Neurogenic Orthostatic Hypotension, Multiple System Atrophy (MSA) With Orthostatic Hypotension, Pure Autonomic Failure Trial in
Completed
- Neurogenic Orthostatic Hypotension
- +7 more
- TD-9855
- Placebo
-
Long Beach, California
- +5 more
Aug 30, 2022
Hypertension, Pure Autonomic Failure, Multiple System Atrophy Trial in Nashville (Heating pad, Sham control)
Recruiting
- Hypertension
- +3 more
- Heating pad
- Sham control
-
Nashville, TennesseeAutonomic Dysfunction Center/ Vanderbilt University Medical Cent
Jan 6, 2022
Orthostatic; Hypotension, Neurogenic, Autonomic Failure, Pure Autonomic Failure Trial in Nashville (Accelerometer, pill,
Recruiting
- Orthostatic; Hypotension, Neurogenic
- +4 more
- Accelerometer
- +2 more
-
Nashville, TennesseeAutonomic Dysfunction Center/ Vanderbilt University Medical Cent
Mar 10, 2022
Orthostatic Hypotension, Pure Autonomic Failure, Multiple System Atrophy Trial in Nashville (Abdominal compression, Sham
Recruiting
- Orthostatic Hypotension
- +3 more
- Abdominal compression
- +3 more
-
Nashville, TennesseeVanderbilt University
Nov 11, 2021
Hypertension, Pure Autonomic Failure, Multiple System Atrophy Trial in Nashville (BQ123, Bq123, Saline)
Withdrawn
- Hypertension
- +2 more
- BQ123
- +2 more
-
Nashville, TennesseeVanderbilt University
Sep 27, 2021
Orthostatic Hypotension, Autonomic Failure, Pure Autonomic Failure Trial in Nashville (automated abdominal binder, Sham binder,
Recruiting
- Orthostatic Hypotension
- +3 more
- automated abdominal binder
- +3 more
-
Nashville, TennesseeAutonomic Dysfunction Center/ Vanderbilt University Medical Cent
Nov 10, 2021
Neurogenic Orthostatic Hypotension Trial in New York, Nashville (Atomoxetine, Placebo)
Completed
- Multiple System Atrophy (MSA)
- Atomexetine
- Placebo
-
New York, New YorkNew York University School of Medicine
Jan 4, 2022
Diabetes, Type 1, Hypoglycemia, Hypoglycemia Unawareness Trial in Bronx (Naloxone, Diazoxide, Placebo (for Naloxone))
Suspended
- Diabetes Mellitus, Type 1
- +2 more
- Naloxone
- +3 more
-
Bronx, New YorkAlbert Einstein College of Medicine
Feb 3, 2022
Supine Hypertension, Autonomic Failure Trial in Nashville (Tilt, Elevated trunk, Tilt - In home)
Recruiting
- Supine Hypertension
- Autonomic Failure
- Tilt
- +3 more
-
Nashville, TennesseeVanderbilt University Medical Center
Sep 27, 2021
Autonomic Failure, Dysautonomia, Cognitive Impairment Trial in Aachen (leg crossing)
Enrolling by invitation
- Autonomic Failure
- +5 more
- leg crossing
-
Aachen, Nordrhein Westfalen, GermanyUniversity Hospital, RWTH Aachen
May 14, 2021
Pure Autonomic Failure, Amyotrophic Lateral Sclerosis, Postural Orthostatic Tachycardia Syndrome Trial in Rozzano
Completed
- Pure Autonomic Failure
- +3 more
- Immunoabsorption/plasmapheresis procedure
-
Rozzano, ItalyHumanitas Research Hospital
May 3, 2021
Natural History Study of Synucleinopathies
Recruiting
- Patients With Synucleinopathies
- +7 more
-
Boston, Massachusetts
- +7 more
Dec 16, 2021
Synuclein-One Study
Recruiting
- Parkinson Disease
- +3 more
- Skin Biopsy
-
Chandler, Arizona
- +22 more
Feb 15, 2022
Autonomic Nervous System Disorders, Pure Autonomic Failure, Shy-Drager Syndrome Trial in Nashville (Angiotensin-(1-7), Saline)
Terminated
- Autonomic Nervous System Disorders
- +3 more
-
Nashville, TennesseeVanderbilt University Medical Center
Jan 8, 2021
Shy-Drager Syndrome, Multiple System Atrophy Trial in Nashville (Pseudoephedrine + 480 ml water, Pseudoephedrine + 50 ml water,
Terminated
- Shy-Drager Syndrome
- Multiple System Atrophy
- Pseudoephedrine + 480 ml water
- +3 more
-
Nashville, TennesseeVanderbilt University
Apr 29, 2021
Diabetes, Hypoglycemia, Autonomic Failure Trial in Bronx (drug, dietary supplement, behavioral)
Active, not recruiting
- Diabetes Mellitus
- +2 more
- naloxone
- +4 more
-
Bronx, New YorkAlbert Einstein College of Medicine / General Clinical Research
Jan 12, 2021